The Company is engaged in the manufacturing, marketing, and distribution of generic pharmaceuticals finished products which include human drug dosage forms like a tablet, capsules, powders for suspension, creams, ointments, powders, injections, eye and nasal drops, liquids, sachets products, oral solution; veterinary drugs dosages form like bolus, liquid, injection, water-soluble powder.
Company s vision :
To become market leader in pharmaceuticals world by winning of stakeholders heart
The Company s mission:
To ensure the best possible range of international quality products at competitive prices through integration, research, innovation continuous development.
History :
1986 : The Company was incorporated in Bangladesh on 31 March 1986 vide registration No. C-15428/994 under the Companies Act - 1913 as a Private Company Limited.
2020 : The Company converted into a Public Limited Company on 30 December 2020.
2022 : The Company has been listed with Dhaka Stock Exchange PLC. and Chittagong Stock Exchange PLC. on October 11, 2022, and October 12, 2022, respectively.
2024 : The Company Changed it s name from Navana Pharmaceuticals Limited to Navana Pharmaceuticals Plc on January 17, 2024 vide registration No. C-15428.
Headquarters
House 99, Road 4, Block B, Banani
Dhaka; Dhaka;
Postal Code: 1213
Contact Details: Purchase the Navana Pharmaceuticals Plc report to view the information.
Website: http://www.navanapharma.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service